Simultaneously occurring liver metastases of pheochromocytoma and medullary thyroid carcinoma--a diagnostic pitfall with clinical implications for patients with multiple endocrine neoplasia type 2a.
Malignant pheochromocytoma is an exceptional complication in patients with Multiple Endocrine Neoplasia Type 2a (MEN2a). In this paper, we report on a 53-year-old male patient with an evident RET gene germline mutation, who simultaneously developed hepatic metastases of medullary thyroid carcinoma (MTC) and pheochromocytoma. Comprehensive immunohistochemical investigations were performed to elaborate markers which could be useful for differentiating between MTC metastases and pheochromocytoma, respectively. Calcitonin and CEA, in particular cytokeratins and trefoil factor family 1 (TFF1), were detectable exclusively in MTC, whereas all the other markers revealed a comparable expression in both MTC and pheochromocytoma. The only clues that could indicate a potential malignant course were size, a lack of sustentacular cells and hyaline globules, and a focal spindle cell pattern in pheochromocytoma. Owing to a wide agreement in cellular differentiation and a lack of specific, routinely applicable markers for pheochromocytomas, a comprehensive and goal-directed immunohistochemistry is required to rule out pheochromocytoma metastasis in patients with MEN2a. A misinterpretation could lead to harmful clinical complications, as shown in the present case.
Hinze
R
R
Institute of Pathology, Martin-Luther-University, Halle, Germany. raoul.hinze@medizin.uni-halle.de
Machens
A
A
Schneider
U
U
Holzhausen
H J
HJ
Dralle
H
H
Rath
F W
FW
D000310:Adrenal Gland Neoplasms / Q000737:chemistry / Q000473:pathology*; D014408:Biomarkers, Tumor / Q000032:analysis; D018276:Carcinoma, Medullary / Q000737:chemistry / Q000556:secondary*; D003937:Diagnosis, Differential; D006801:Humans; D007150:Immunohistochemistry; D008113:Liver Neoplasms / Q000737:chemistry / Q000556:secondary*; D008875:Middle Aged; D018813:Multiple Endocrine Neoplasia Type 2a / Q000737:chemistry / Q000473:pathology*; D010673:Pheochromocytoma / Q000737:chemistry / Q000556:secondary*; D013964:Thyroid Neoplasms / Q000737:chemistry / Q000473:pathology*
D014408:Biomarkers, Tumor